Results 71 to 80 of about 32,390 (296)

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF

European Heart Journal, 2018
Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) with preserved ejection fraction (HFpEF) has been limited.
Sanjiv J. Shah, C. Lam, S. Svedlund, A. Saraste, C. Hage, R. Tan, L. Beussink-Nelson, M. Fermer, Malin Broberg, L. Gan, L. Lund   +10 more
semanticscholar   +1 more source

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study

Scientific Reports, 2021
Impaired left atrial (LA) function in heart failure with preserved ejection fraction (HFpEF) is associated with adverse outcomes. A subgroup of HFpEF may have LA myopathy out of proportion to left ventricular (LV) dysfunction; therefore, we sought to ...
Ravi B. Patel, C. Lam, S. Svedlund, A. Saraste, C. Hage, R. Tan, L. Beussink-Nelson, J. Tromp, Cynthia L Sanchez, Joyce N. Njoroge, Stan A Swat, U. L. Faxén, M. Fermer, A. Venkateshvaran, L. Gan, L. Lund, Sanjiv J. Shah   +16 more
semanticscholar   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Echocardiographic and Clinical Correlates of Ejection Fraction Among 2000 Patients with Heart Failure in Western Saudi Arabia

International Journal of General Medicine, 2020
Ahmed Hussein Subki,1 Mohammed Ali Almalki,2 Nadeem Shafique Butt,3 Mohammed Saad Alsallum,4 Hatim Mashan Almutairi,5 Hazim Abdulkarim Khatib,6 Abdulrahman Mousa Alzahrani,6 Abdullah Salem Babaker,6 Firas Abdulrahman Addas,6 Abdullah Abdulfattah Mashat,7
Subki AH, Almalki MA, Butt NS, Alsallum MS, Almutairi HM, Khatib HA, Alzahrani AM, Babaker AS, Addas FA, Mashat AA, Jad AY, Zafar ZA, Nogali BW, Alghamdi AA, Alghamdi NA, Dakhakhni MF, Asaad OT, Alghalayini KW   +17 more
doaj  

Comparison of Electrocardiographic Parameters by Gender in Heart Failure Patients with Preserved Ejection Fraction via Artificial Intelligence

Diagnostics, 2023
Background: Heart failure (HF) causes high morbidity and mortality worldwide. The prevalence of HF with preserved ejection fraction (HFpEF) is increasing compared with HF with reduced ejection fraction (HFrEF).
Rustem Yilmaz, Ersoy Öz
doaj   +1 more source

Lessons Learned from Community Studies of HFpEF – The Digitalis Study [PDF]

, 2022
Eduarda Corrêa Maia, Evandro Tinoco Mesquita, Antônio José Lagoeiro Jorge, Luiz Cláudio Danzmann   +3 more
openalex   +1 more source

Precision Cardiology: Phenotype-targeted Therapies for HFmrEF and HFpEF.

International Journal of Heart Failure
Heart failure with mid-range ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF) represent over half of heart failure cases but lack proven effective therapies beyond sodium-glucose cotransporter 2 inhibitor and diuretics. HFmrEF and HFpEF
Giuseppe M C Rosano, C. Vitale, I. Spoletini   +2 more
semanticscholar   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.

PLoS ONE, 2022
Heart failure is a leading cause of hospitalizations and mortality worldwide. Heart failure with a preserved ejection fraction (HFpEF) represents a significant clinical challenge due to the lack of available treatment modalities for patients diagnosed ...
Yuhua Zhang, An O Van Laer, Catalin F Baicu, Lily S Neff, Stanley Hoffman, Marc R Katz, Sanford M Zeigler, Michael R Zile, Amy D Bradshaw   +8 more
doaj   +1 more source

Modulating Cardiac Hemodynamics Using Tunable Soft Robotic Sleeves in a Porcine Model of HFpEF Physiology for Device Testing Applications [PDF]

, 2023
Luca Rosalia, Çağlar Öztürk, Sophie X. Wang, Diego Quevedo‐Moreno, Mossab Y. Saeed, Adam Mauskapf, Ellen T. Roche   +6 more
openalex   +1 more source